ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 359,53
0,03%
Dow Jones
43 717,48
0,00%
DAX
20 278,81
-0,17%
Brent Oil
72,925
-1,00%
Bitcoin
107 500,35
1,34%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Reviva Pharmaceuticals Holdings Inc (RVPH)

  7. Reviva Pharmaceuticals Holdings Inc (RVPH) Actualités

RVPH

Reviva Pharmaceuticals (RVPH)

Reviva Pharmaceuticals Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RVPH
DateHeureSourceTitreSymboleSociété
23/08/202422h06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
22/08/202423h04Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
22/08/202415h28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
21/08/202423h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/08/202414h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
16/02/202422h32Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
13/02/202423h00Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
02/02/202422h38Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202323h19Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202323h03Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/06/202312h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
15/05/202322h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
05/05/202322h31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
27/04/202322h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202314h12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202314h07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202313h52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/02/202322h03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
16/11/202220h35TipRanksReviva Pharmaceuticals Holdings (RVPH) Receives a Buy from Maxim GroupNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/08/202217h25TipRanksMaxim Group Keeps Their Buy Rating on Reviva Pharmaceuticals Holdings (RVPH)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/06/202214h35GlobeNewswire Inc.Life Sciences Investor Forum Presentations Now Available for On-Demand ViewingNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/03/202212h30GlobeNewswire Inc.Reviva Pharmaceuticals Holdings, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/03/202221h16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/03/202211h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
26/01/202222h15Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/01/202212h15TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Alnylam Pharma (ALNY), Reviva Pharmaceuticals Holdings (RVPH)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
26/10/202113h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
03/06/202123h31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
28/05/202122h10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:RVPH

Dernières Valeurs Consultées

EU
ML
Michelin
EU
SGO
Cie de SaintGobain
EU
AF
Air FranceKLM
EU
BEL20
Bel 20
EU
CAP
Capgemini
COIN
AVAXUSD
Avalanche
NYSE
DIS
Walt Disney
EU
AI
Air Liquide
EU
GLE
Societe Generale
EU
RNO
Renault
EU
ACA
Credit Agricole
NASDAQ
MSFT
Microsoft
EU
PX4
SBF 120
EU
RI
Pernod Ricard
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés